PepGen (PEPG) Interest Coverage Ratio (2021 - 2026)
PepGen (PEPG) reported Interest Coverage Ratio of 611.03 for Q1 2026, down 1.45% on a YoY basis from 619.99 in Q1 2025, and up 28.51% sequentially from 854.71 in Q2 2025.
PepGen (PEPG) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Interest Coverage Ratio data on file, last reported at 611.03 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 1.45% year-over-year to 611.03; the trailing twelve-month figure through Mar 2026 stood at 2620.42 (down 24.71% YoY), and the FY2025 full-year result was 6.41, up 80.3% from the prior year.
- Interest Coverage Ratio advanced to 611.03 in Q1 2026, from 854.71 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.58 in Q1 2023 to a low of 1544.73 in Q3 2024.
- A 5-year average of 401.33 and a median of 42.12 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio surged 87.91% in 2023 and sank 170084.18% in 2024, its largest moves.
- Tracing PEPG's Interest Coverage Ratio over 5 years: stood at 1.34 in 2022, then plunged by 2012.44% to 28.24 in 2023, then tumbled by 49.16% to 42.12 in 2024, then plunged by 1929.27% to 854.71 in 2025, then grew by 28.51% to 611.03 in 2026.
- Business Quant data shows PEPG's Interest Coverage Ratio at 611.03 in Q1 2026, 854.71 in Q2 2025, and 602.33 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | -611.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -611.03 |
| Jun 30, 2025 | -854.71 |
| Mar 31, 2025 | -602.33 |
| Dec 31, 2024 | -42.12 |
| Sep 30, 2024 | -1,544.73 |
| Jun 30, 2024 | -533.77 |
| Mar 31, 2024 | -989.90 |
| Dec 31, 2023 | -28.24 |
| Sep 30, 2023 | -2.97 |
| Jun 30, 2023 | -0.70 |
| Mar 31, 2023 | -0.58 |
| Dec 31, 2022 | -1.34 |
| Mar 31, 2022 | -4.81 |
| Dec 31, 2021 | -1.01 |